Lincoln Electric Board Declares Dividend
Feb 17, 2016 21:30 pm UTC| Business
CLEVELAND, Feb. 17, 2016 -- Lincoln Electric Holdings, Inc., (Nasdaq:LECO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.32 per common share, payable April 15, 2016 to...
Emclaire Financial Corp Announces 8.3% Quarterly Dividend Increase
Feb 17, 2016 21:30 pm UTC| Business
EMLENTON, Penn., Feb. 17, 2016 -- The Board of Directors of Emclaire Financial Corp (NASDAQ:EMCF), the parent holding company of the Farmers National Bank of Emlenton, declared a quarterly cash dividend on February 17,...
Feb 17, 2016 21:15 pm UTC| Business
REDWOOD CITY, Calif., Feb. 17, 2016 -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that the company will report its fourth quarter and full year 2015 financial results on Wednesday,...
Great Lakes Announces Award of Approximately $58 Million in Dredging Projects
Feb 17, 2016 21:15 pm UTC| Business
OAK BROOK, Ill., Feb. 17, 2016 -- Great Lakes Dredge Dock Corporation (“Great Lakes”) (NASDAQ:GLDD), the largest provider of dredging services in the United States and a major provider of environmental and remediation...
Feb 17, 2016 21:15 pm UTC| Business
MCLEAN, Va., Feb. 17, 2016 -- Gladstone Commercial Corporation (NASDAQ:GOOD), or the Company, today reported financial results for the fourth quarter and year ended December 31, 2015. A description of funds from...
Crown Castle to Present at the Morgan Stanley 2016 Technology, Media & Telecom Conference
Feb 17, 2016 21:15 pm UTC| Business
HOUSTON, Feb. 17, 2016 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that Jay Brown, Crown Castle’s Chief Financial Officer, is scheduled to present on Tuesday, March 1, 2016 at 4:50...
SteadyMed to Present at RBC Capital Markets 2016 Global Healthcare Conference
Feb 17, 2016 21:15 pm UTC| Business
SAN RAMON, Calif., Feb. 17, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a pre-NDA stage specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet...